Balhimycin
Also known as: A82846B analog, Amycolatopsis balhimycina antibiotic, Balhimycin, Balhimycin A
Source Balhimycin at Peptiology
Save 10% with code PEPTI-BOSSRABBIT-10
Tapping Shop Now & Save 10% copies your 10% off code PEPTI-BOSSRABBIT-10 to your clipboard. Paste it at the Peptiology checkout to claim the discount.
Summary
Balhimycin is a natural glycopeptide antibiotic produced by Actinomadura balhimycina, structurally related to vancomycin and studied for activity against resistant Gram‑positive pathogens.
Mechanism of Action
Binds the D-Ala-D-Ala terminus of peptidoglycan precursors, inhibiting cell‑wall synthesis in Gram‑positive bacteria
Routes of Administration
Goals & Uses
- Antibiotic resistance mechanism studyBasic ScienceModerate
- Glycopeptide biosynthesis elucidationBasic ScienceHigh
- Treatment of multidrug‑resistant Gram‑positive infectionsAntibacterial TherapyModerate
- Gram-positive bacterial infection researchAntimicrobial ResearchLow
Contraindications
- Known hypersensitivity to glycopeptide antibioticsAllergyHigh
Adverse Effects
- Red man syndromeInfusion ReactionUnknown
- NephrotoxicityRenalUnknown
Drug Interactions
- AminoglycosidesModerate
Population Constraints
- Pregnant womenReproductiveRelative
Regulatory Status
- European UnionInvestigationalUnder clinical evaluation; not authorized for marketing.
- United StatesInvestigationalOnly available under IND for clinical trials.
- United KingdomUnapprovedNo MHRA approval; research compound only.
Not approved for human use in any jurisdiction; limited to pre‑clinical and early‑phase clinical investigations.
Evidence & Sources
No sources recorded yet.
Frequently Asked Questions
What is Balhimycin?
Balhimycin is a natural glycopeptide antibiotic produced by Actinomadura balhimycina, structurally related to vancomycin and studied for activity against resistant Gram‑positive pathogens.
What is Balhimycin used for?
Balhimycin is educationally associated with: Antibiotic resistance mechanism study, Glycopeptide biosynthesis elucidation, Treatment of multidrug‑resistant Gram‑positive infections, Gram-positive bacterial infection research. Educational only — not medical advice.
How is Balhimycin administered?
Recorded routes of administration: Intramuscular, Intravenous, Topical.
What are the potential side effects of Balhimycin?
Reported adverse effects include: Red man syndrome, Nephrotoxicity. This list is not exhaustive — consult a qualified clinician.
Who should avoid Balhimycin?
Recorded contraindications: Known hypersensitivity to glycopeptide antibiotics. Consult a qualified clinician before use.